The Effect of Valerian on Insomnia in Menopausal Women: Randomized Placebo-controlled Trial
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Menopausal women often complain that it is difficult to fall asleep and easy to wake up at night and early in the morning and it is in the middle of night difficult to fall asleep again. If the above symptoms persist for at least three months and occur at least three times a week, plus the impact on daytime work and rest, and meet the International Classification of Sleep Disorders (ICSD-3) )'S s Insomnia diagnostic criteria. According to statistics, 30% to 60% of women face sleep disorders during menopause.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 45
Maximum Age: 60
Healthy Volunteers: t
View:
• 45〜60 years old, and is menopaused for at least 1 year。
• meet the criteria of ICSD-3 for insomnia
• PSQI \> 5
Locations
Other Locations
Taiwan
China Medical University
RECRUITING
Taichung
Contact Information
Primary
Shan-Yu Su
shanyusu@gmail.com
0975682032
Time Frame
Start Date: 2021-12-14
Estimated Completion Date: 2025-01-20
Participants
Target number of participants: 100
Treatments
Experimental: Valerian
generic name: XIE CAO CONC dosage form: capsule dosage: 500 mg/capsule, 6 capsules a day frequency: 3 times a day after each meal, 2 capsules each time duration: 30 days
Placebo_comparator: Control
generic name: placebo (Caramel Colors dyed starch) dosage form: capsule dosage: 500 mg/capsule, 6 capsules a day frequency: 3 times a day after each meal, 2 capsules each time duration: 30 days
Sponsors
Leads: China Medical University Hospital